OGE Energy Corp. announced its quarterly earnings and business update conference call will take place on October 28, 2026, at 9 a.m. Eastern Time. Investors and interested parties can listen to the live webcast through OGE Energy's official website. This event provides an opportunity to hear the company's latest financial results and strategic updates directly from management.
OGE Energy Corp.'s upcoming third quarter 2026 earnings webcast is announced for October 28, 2026. For readers following the Utilities sector, here is Pluang's market snapshot as of September 30, 2026, 03:22 WIB: out of 22 priced Utilities-sector US stocks tradable on Pluang, 16 rose and 6 fell. Notable movers include NextEra Energy, Inc. (NEE) at USD 75.91 with a 1-day change of +0.56% and a typical hold time of 82 days, American States Water Company (AWR) at USD 81.76 with a 1-day change of +0.50% and 100% buy order activity, and H2O America (HTO) at USD 61.67 with a 1-day change of +0.49%.
GameStop's CEO Ryan Cohen and other executives have made significant insider purchases of millions of shares, showing strong confidence in the company's future despite recent stock price volatility. These buys were active decisions, not pre-scheduled...
Concentrix Corporation reported mixed Q3 2026 results with earnings per share of $2.92, beating analyst expectations of $2.71. However, its revenue of $2.45 billion slightly missed the forecast of $2.48 billion. The company achieved a record free cas...
Accenture is set to report Q3 2026 earnings on October 1, with analysts forecasting $18.03 billion in revenue, a 5.6% increase year-over-year, and earnings per share around $3.18. The growth is fueled by strong demand for AI services, with 100 new ad...
Iovance Biotherapeutics shares jumped 31.48% after raising its 2026 revenue forecast, driven by strong demand for its cancer immunotherapy Amtagvi. SoundThinking's stock rose 50.09% following an acquisition agreement with Transom Capital Group, offer...
Shares of uniQure dropped 37.33% following mixed clinical data for its Huntington's disease gene therapy. Fair Isaac fell 26.52% after U.S. regulators expanded the use of competitor VantageScore in mortgage credit scoring, threatening its market posi...
